Showing results (71-80 of 146) with videos related to
Sort By:
Pageof 15
Journal of Thrombosis and Haemostasis : JTH|April 6, 2007
A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacementG Agnelli, S Haas, J S Ginsberg, et al.Journal of Thrombosis and Haemostasis : JTH|May 5, 2005
Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control studyJ D Douketis, J A Julian, C Kearon, et al.Archives of Internal Medicine|December 9, 2000
Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapyJ D Douketis, G A Foster, M A Crowther, et al.Archives of Internal Medicine|May 22, 2002
Suspected pulmonary embolism in pregnancy: clinical presentation, results of lung scanning, and subsequent maternal and pediatric outcomesW S Chan, J G Ray, S Murray, et al.Thrombosis Research|September 30, 2000
The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literatureJ D Douketis, M Gordon, M Johnston, et al.Lancet (London, England)|June 20, 2000
Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysisJ W Eikelboom, S S Anand, K Malmberg, et al.Journal of Thrombosis and Haemostasis : JTH|September 9, 2014
Comparison of the effects of apixaban and rivaroxaban on prothrombin and activated partial thromboplastin times using various reagentsB J Dale, J S Ginsberg, M Johnston, et al.Archives of Internal Medicine|June 14, 2001
Deep vein thrombosis and its prevention in critically ill adultsJ Attia, J G Ray, D J Cook, et al.Archives of Internal Medicine|September 26, 2001
Prevention and treatment of postphlebitic syndrome: results of a 3-part studyJ S Ginsberg, J Hirsh, J Julian, et al.Thrombosis and Haemostasis|May 4, 1992
Measurement of markers of activated coagulation in antithrombin III deficient subjectsC Demers, J S Ginsberg, P Henderson, et al.Pageof 15